Latest Breaking News On - Don domoretsky - Page 1 : comparemela.com

Boston Has A Dire Shortage Of Biomanufacturing Facilities The red-hot life sciences market in and around Boston is lacking a critical piece as its growing companies look to expand. Biomanufacturing facilities are few and far between in the region, and biopharmaceutical companies are scrambling for solutions, experts said. New medicines require fundamentally different manufacturing than the drugs of the past, meaning most of these facilities need to be built new. Courtesy of King Street Properties A rendering of King Street Properties 45-acre biomanufacturing campus in Devens. “There’s a dire shortage of this kind of real estate,” King Street Properties principal Stephen Lynch said. “There doesn’t exist, in the U.S., an organized real estate market for this product type. The end users, the companies that need to make these drugs, are scrambling for solutions.”

United statesUnited kingdomStephen lynchTom hochuliSteve purpuraDon domoretskyRaleigh durham research triangleDevens permitting authorityOncorus incMassachusetts biotechnology councilCourtesy propertiesKing streetKing street propertieStreet propertiesEast cambridge based oncorusPresident doug cuff